IL33 and idiopathic pulmonary fibrosis: Therefore, IL-33 is a novel profibrogenic factor that promotes the initiation and progression of BLM-induced IPF by recruiting inflammatory cells and enhancing profibrogenic cytokine production in a macrophage-dependent manner (Li et al., 2014).